Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Drive by prescription drugs, national health spending up in 2019

National health spending reached $3.76 trillion in March 2019, a 4.6% jump from the same month in 2018, according to recent data from Altarum, underscoring signs of acceleration during the first quarter of 2019.

Thumbnail

JPMorgan Chase drops $500M on healthcare payment system

JPMorgan Chase has acquired InstaMed, a technology company with a focus in healthcare payments, for a purchase price of more than $500 million.

Thumbnail

CMS expands step therapy, backs off controversial pricing proposal in final rule

CMS finalized a rule that aims to boost transparency of the cost of prescription drugs in Medicare Part D and enable Medicare Advantage plans to negotiate better prices for medicines. Notably, the final version backs off a controversial proposal that would have allowed Medicare Part D plans to exclude certain drugs if prices rise beyond a threshold.

 

Thumbnail

Physicians top $2M in revenue at hospitals

Physicians are bringing in more revenue at hospitals in 2019 than previously, according to a recent report from Merritt Hawkins.

Thumbnail

CMS issues guidance to cut spread pricing in Medicaid

CMS has issued a new guidance to limit the prevalence of spread pricing in Medicaid and the Children’s Health Insurance Program (CHIP) as part of a broader effort to lower prescription drug costs.

Thumbnail

How rural America is grappling with hospital closures

Rural hospitals are closing at a quick pace, leaving communities at a loss after sometimes long-standing institutions shutter their doors. In Fort Scott, Kan., the closure of a 132-year-old hospital had to be reckoned with, and the closure brings up the question of if small towns need a traditional hospital at all, NPR reported.

Thumbnail

20 drug companies hit with lawsuit for inflating drug prices

Forty-four U.S. states have joined together in a lawsuit against 20 drug manufacturers, accusing them of scheme to inflate drug prices and eliminate competition in the market, Reuters reported. The drugmakers are accused of jacking up the prices by more than 1,000% in some cases.

Thumbnail

How New York stopped surprise billing

As the Trump administration looks for ways to reduce the burden on Americans when they receive a surprise medical bill, it could borrow ideas from New York, which approved legislation in 2014 that has safeguarded residents in the state from being hit with out-of-network charges.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup